Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tower Health operates a large regional integrated healthcare system in Pennsylvania, providing acute care, specialty services, urgent care, rehabilitation, home health, and academic medicine. Its flagship Reading Hospital has received national recognition for excellence in multiple specialties including neurosurgery/stroke, cardiac/vascular surgery, trauma/oncology. The system partners with Drexel University for medical education and research.
Recent strategic partnerships include a 10-year Value Partnership with Siemens Healthineers to modernize diagnostic imaging and oncology/cardiology technology across the network.
The system’s hospitals have been recognized by U.S. News & World Report for high performance in areas such as gastroenterology/GI surgery, geriatrics, orthopedics, pulmonary/lung surgery, urology; regionally high performing in COPD management, colon cancer surgery, diabetes care/management of heart attack/failure/kidney failure/pneumonia/stroke/joint replacement.
No drug development or biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tower Health.